Pennsylvania Department of Health
BARNES-KASSON COUNTY HOSPITAL SNF
Patient Care Inspection Results

Note: If you need to change the font size, click the "View" menu at the top of the page, place the mouse over the "Text Size" menu item, and select the desired font size.

Severity Designations

Click here for definitions Click here for definitions Click here for definitions Click here for definitions
Minimal Citation - No Harm Minimal Harm Actual Harm Serious Harm
BARNES-KASSON COUNTY HOSPITAL SNF
Inspection Results For:

There are  57 surveys for this facility. Please select a date to view the survey results.

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.
BARNES-KASSON COUNTY HOSPITAL SNF - Inspection Results Scope of Citation
Number of Residents Affected
By Deficient Practice
Initial comments:

Based on a Medicare/Medicaid Recertification, State Licensure and Civil rights Compliance Survey completed on August 6, 2026, it was determined Barnes Kasson County Hospital Skilled Nursing Facility was not in compliance with the following requirements of 42 CFR, Subpart B, Requirements for Long Term Care and the 28 PA Code, Commonwealth of Pennsylvania Long Term Care Licensure Regulations.




 Plan of Correction:


483.25(b)(1)(i)(ii) REQUIREMENT Treatment/Svcs to Prevent/Heal Pressure Ulcer:This is a more serious deficiency but is isolated to the fewest number of residents, staff, or occurrences. This deficiency results in a negative outcome that has negatively affected the resident's ability to achieve his/her highest functional status.
§483.25(b) Skin Integrity
§483.25(b)(1) Pressure ulcers.
Based on the comprehensive assessment of a resident, the facility must ensure that-
(i) A resident receives care, consistent with professional standards of practice, to prevent pressure ulcers and does not develop pressure ulcers unless the individual's clinical condition demonstrates that they were unavoidable; and
(ii) A resident with pressure ulcers receives necessary treatment and services, consistent with professional standards of practice, to promote healing, prevent infection and prevent new ulcers from developing.
Observations:

Based on clinical record review, facility policy review, observation, and staff interviews, it was determined that the facility failed to consistently implement interventions to prevent the development and worsening of pressure injuries for one of 12 residents reviewed (Resident 2). This failure resulted in actual harm when Resident 2 developed a Stage 2 pressure injury that subsequently deteriorated and was identified as an unstageable pressure injury.

Findings include:

According to the National Pressure Injury Advisory Panel (NPUAP) September 2025 a pressure injury is localized damage to the skin and underlying soft tissue. The skin injury occurs due to intense and/ or prolonged pressure or pressure in combination with shear. Preventive measures include various interventions such as the use of high-quality static pressure-reducing mattress (a mattress specially designed to spread body weight evenly to prevent high-pressure spots such as the hips, shoulders, and tailbone), staff assisting and encouraging mobility, and applying barrier creams.

Review of the facility policy titled "Skin Assessment/Braden Scale," last reviewed July 1, 2026, revealed the facility evaluates residents for risk of impaired skin integrity and pressure injury development using the Braden Scale, a standardized tool used to identify pressure injury risk. The Braden scale is a standard instrument to evaluate the risk for skin breakdown due to pressure; the total score is 6-23. The lower the score the higher the risk for pressure injury development.

Review of the facility policy titled "Pressure Sore Staging and Treatments," last reviewed July 1, 2026, revealed the resident's plan of care was to include preventive measures to maintain skin integrity and interventions to address identified skin problems. The policy also required routine skin assessment by a Registered Nurse and documentation of identified skin problems and the effectiveness of interventions.

A clinical record review revealed Resident 2 was admitted to the facility on December 2, 2024, with diagnoses that included obesity (general term used to describe a condition in which a person has an excessive amount of body fat). Resident 2 was admitted to an acute care facility on May 2, 2026, and returned to the facility on May 11, 2026.

A "Skin Only Evaluation" dated May 12, 2026, identified multiple pressure injuries involving Resident 2's gluteal and buttock-fold areas, including a Stage 2 (Stage 2 pressure injury involves partial-thickness loss of skin with exposed underlying skin tissue) pressure injury to the right gluteal fold measuring 0.8 centimeter (cm) by 0.6 cm.

A Braden Scale assessment dated May 11, 2026, identified Resident 2 as at moderate risk for developing pressure injuries with a score of 12. Identified risk factors included moisture, limited mobility, inability to independently reposition, and the need for moderate to maximum assistance with movement.

A review of Resident 2's reentry Minimum Data Set assessment (MDS, a federally mandated standardized assessment process conducted periodically to plan resident care) dated May 18, 2026, revealed that Resident 2 had severe cognitive impairment with a BIMS score of 5 (Brief Interview for Mental Status, a tool within the Cognitive Section of the MDS that is used to assess the resident's attention, orientation, and ability to register and recall new information; a score of 0-7 means severe cognitive impairment, significant difficulties with knowing the year, month, weekday and/or delayed memory recall) and indicated Resident 2 required the assistance of two staff members for repositioning in bed and transfers from bed to the chair and vice versa. The MDS indicated the resident had two Stage 2 pressure ulcers upon reentry to the facility.

A physician's order dated April 13, 2026, directed staff to turn and reposition Resident 2 hourly from side to side. A physician's order dated May 2, 2026, directed use of an alternating air mattress for pressure reduction.

Resident 2's care plan, revised May 2, 2026, identified the resident as having impaired skin integrity and being at risk for additional skin injury. Interventions included hourly side-to-side repositioning, use of an alternating air mattress to redistribute pressure, routine skin monitoring, and encouraging adequate nutrition and fluid intake.

Nursing documentation dated June 21, 2026, indicated that all remaining Stage 2 pressure injuries involving Resident 2's left and right gluteal folds had resolved.

Despite the physician's order and care-planned intervention directing staff to reposition Resident 2 hourly from side to side, review of the July 2026 Documentation Survey Report revealed multiple hourly repositioning checks between July 1 and July 15, 2026, when staff documented Resident 2 lying on their back rather than positioned from side to side as ordered.

A "Skin Only Evaluation" dated July 15, 2026, completed by Employee 2, Licensed Practical Nurse (LPN), identified a painful Stage 2 pressure injury to Resident 2's right gluteal fold/buttock measuring 6.2 cm in length by 4.8 cm in width by 0.1 cm in depth.

Treatment included cleansing the pressure injury with Vashe (a wound-cleansing solution), applying Triad paste (a protective wound dressing paste applied to damaged skin to help protect the area and manage wound moisture), and covering the area with a bordered dressing (a protective wound covering with an adhesive border) every Monday, Wednesday, and Friday, and as needed if the dressing became soiled. The treatment also directed staff to apply barrier cream (a protective cream used to shield the skin from moisture and irritation) with every incontinence product change.

Despite the development of the Stage 2 pressure injury and the existing physician's order for hourly side-to-side repositioning, staff continued to document Resident 2 lying on their back during 60 separate hourly repositioning checks between July 15 and July 23, 2026, rather than positioned from side to side as ordered.

A "Skin Only Evaluation" dated July 23, 2026, completed by Employee 2, LPN, documented that the affected area had changed in appearance. Employee 2 classified the area as a suspected deep tissue pressure injury (DTI) involving the right thigh/gluteal fold measuring 4 cm by 4 cm, with the depth unable to be determined. A DTI is damage to underlying tissue that may appear as persistent dark red, maroon, or purple discoloration.

The July 23, 2026, treatment directed staff to cleanse the area and apply Balmex (a barrier cream used to protect the skin from moisture and irritation) every shift and to apply barrier cream with every incontinence product change.

Between July 23 and July 27, 2026, staff documented Resident 2 lying on their back during an additional 32 separate hourly repositioning checks rather than positioned from side to side as ordered.

A "Skin Only Evaluation" dated July 27, 2026, completed by Employee 2, LPN, documented further deterioration of the affected area and classified the pressure injury as unstageable, measuring 4.8 cm by 5.2 cm. An unstageable pressure injury involves full-thickness skin and tissue loss in which the extent of tissue damage cannot be determined because the wound is obscured by dead tissue.

The July 27, 2026, evaluation also documented placement of a urinary catheter, a tube inserted into the bladder to drain urine, to assist with keeping the affected area dry and support healing.

Despite the documented deterioration of the pressure injury, staff continued to document Resident 2 lying on their back during an additional 58 separate hourly repositioning checks between July 27 and August 5, 2026, rather than positioned from side to side as ordered.

On August 4, 2026, at 11:13 AM Resident 2 was observed lying on their back in bed on the ordered alternating air mattress. The control unit responsible for operating the alternating air mattress was turned off. The mattress control was set for a resident weight of 320 pounds. Resident 2's documented weight on July 22, 2026, was 203 pounds. According to the manufacturer's guidelines, proper weight setting supports pressure redistribution and comfort. Setting the mattress at the proper weight helps prevent pressure ulcers by keeping pressure levels within a safe range while offering alternating pressure cycles, typically around every 10 minutes to shift loading points.

An August 5, 2026, "Skin Only Evaluation," completed by Employee 2, LPN, documented continued deterioration of Resident 2's skin condition. The unstageable pressure injury involving the right thigh/gluteal fold measured 9.6 cm by 11.2 cm. The evaluation also documented deep tissue damage to the posterior right thigh and seven additional Stage 2 open areas.

Treatment was changed to cleansing the affected area with Vashe and applying Triad paste every shift. A physician's order also directed that Resident 2 be evaluated by an outside wound clinic.

On August 5, 2026, at 10:30 AM during an observation with Employee 1, RN, Resident 2's posterior thigh/lower buttock area contained a large bright red and purple area with seven open areas within the affected area. The open areas appeared bright red. No drainage or odor was observed.

The measurements for the seven Stage 2 pressure injuries contained within the DTI included:

2.3 cm (length) x 0.3 cm (width) x 0.2 cm (depth)
0.7 cm (length)x 0.4 cm (width)x 0.2 cm (depth)
0.4 cm (length)x 0.3 cm (width) x 0.2 cm (depth)
0.6 cm (length)x 0.2 cm (width) x 0.2 cm (depth)
0.2 cm (length)x 0.2 cm (width) x 0.2 cm (depth)
0.3 cm (length)x 0.1 cm (width) x 0.2 cm (depth)
0.4 cm (length)x 0.5 cm (width)x 0.2 cm (depth)

During an interview on August 5, 2026, at 11:40 AM the Director of Nursing confirmed that the clinical record did not demonstrate consistent implementation of interventions, including repositioning, to prevent further deterioration of Resident 2's skin condition. The Director of Nursing was unable to explain why the alternating air mattress control unit was turned off or why the mattress was set for 320 pounds when Resident 2's documented weight was 203 pounds.

During an interview on August 5, 2026, at 11:40 AM the Director of Nursing confirmed that Employee 2, LPN, completed the facility's wound evaluations and that an RN was expected to oversee the evaluations and agree or disagree with the findings.

During an interview on August 6, 2026, at 10:00 AM Employee 2 confirmed that she completed Resident 2's wound evaluations, including wound staging and treatment recommendations, and confirmed that Resident 2's pressure injury continued to deteriorate following its identification on July 15, 2026.

The clinical record lacked evidence that an RN assessed Resident 2's pressure injury as required by facility policy as the pressure injury changed in appearance and deteriorated. Employee 2, LPN, completed the documented wound evaluations on July 15, July 23, July 27, and August 5, 2026.

The facility's failure to consistently implement ordered and care-planned pressure-relieving interventions resulted in actual harm to Resident 2, as evidenced by the development of a painful Stage 2 pressure injury and subsequent deterioration of the affected area to an unstageable pressure injury, with continued deterioration and additional areas of skin breakdown.

The findings were reviewed during an interview on August 6, 2026, at 1:45 PM with the Director of Nursing and Nursing Home Administrator.


28 Pa. Code 211.10(c)(d) Resident care policies.

28 Pa. Code 211.12(c)(d)(1)(3)(5) Nursing services.


 Plan of Correction - To be completed: 09/21/2026

1. Corrective Action for Resident 2
Resident 2 will be assessed by an RN, with current skin conditions, treatments, repositioning requirements, support surfaces, and care plan reviewed and updated as indicated. The alternating air mattress will be verified as operational and set according to the resident's current weight/manufacturer recommendations. Physician and wound-care recommendations will be implemented and monitored.
2. Identification of Other Residents
The DON/designee will identify residents with pressure injuries or at risk for skin breakdown and audit their physician orders, care plans, repositioning interventions, skin assessments, treatments, and pressure-relieving equipment. Any identified concerns will be corrected promptly.
3. Systemic Changes
Licensed nurses and CNAs will be re-educated on pressure-injury prevention, ordered repositioning schedules, accurate documentation, proper use of pressure-relieving mattresses/equipment, timely reporting of skin changes, and following the resident's plan of care. Licensed nurses will also be educated on required RN assessment and oversight of pressure injuries in accordance with facility policy. The facility will coordinate education for licensed nursing staff on F686 by an approved directed in-service provider. Directed in-service provider tentatively scheduled for 9/9.
4. Monitoring
The DON/designee will audit compliance with repositioning, pressure-relieving equipment, skin assessments, treatment orders, and RN oversight 5x weekly for 4 weeks, then weekly for 8 weeks. Identified concerns will receive immediate corrective action and staff re-education as indicated. Results will be reviewed through the facility's QAPI process to determine the need for continued monitoring.

483.20(g)(h)(i)(j) REQUIREMENT Accuracy of Assessments:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.20(g) Accuracy of Assessments.
The assessment must accurately reflect the resident's status.

§483.20(h) Coordination. A registered nurse must conduct or coordinate each assessment with the appropriate participation of health professionals.

§483.20(i) Certification.
§483.20(i)(1) A registered nurse must sign and certify that the assessment is completed.
§483.20(i)(2) Each individual who completes a portion of the assessment must sign and certify the accuracy of that portion of the assessment.

§483.20(j) Penalty for Falsification.
§483.20(j)(1) Under Medicare and Medicaid, an individual who willfully and knowingly-
(i) Certifies a material and false statement in a resident assessment is subject to a civil money penalty of not more than $1,000 for each assessment; or
(ii) Causes another individual to certify a material and false statement in a resident assessment is subject to a civil money penalty or not more than $5,000 for each assessment.
§483.20(j)(2) Clinical disagreement does not constitute a material and false statement.
Observations:

Based on review of the Resident Assessment Instrument (RAI) Manual, clinical records, resident observation, and staff interviews, it was determined that the facility failed to ensure the Minimum Data Set (MDS), accurately reflected the residents' clinical status for two of 12 residents reviewed (Residents 2 and 9).

Findings include:

The Long-Term Care Facility Resident Assessment Instrument (RAI) User's Manual, which provides instructions and guidelines for completing the Minimum Data Set (MDS a federally mandated standardized assessment conducted at specific intervals to plan resident care) dated October 2025, requires the assessment accurately reflects the resident's status, a registered nurse conducts or coordinates each assessment with the appropriate participation of health professionals, and the assessment process includes direct observation, as well as communication with the resident and direct care staff on all shifts.

A clinical record review revealed Resident 2 was admitted to the facility on December 2, 2024 with diagnoses that included but not limited to obesity (general term used to describe a condition in which a person has an excessive amount of body fat), pressure ulcers (injury to the skin and underlying tissue caused by prolonged pressure), peripheral vascular disease (a condition that reduces blood flow through blood vessels outside the heart and brain), and cellulitis (bacterial infection of the skin and underlying tissue) of the right lower leg.

A review of a clinical record titled "Skin Only Evaluation," dated May 12, 2026, documented that Resident 2 had a Stage 3 pressure injury of the coccyx (a pressure-related wound over the tailbone involving full-thickness loss of skin).

A review of Resident 2's reentry admission Minimum Data Set (MDS), with an Assessment Reference Date of May 18, 2026, revealed Section M, Skin Conditions, was coded with a "0" (zero) for Stage 3 pressure injuries, indicating the resident did not have any Stage 3 pressure injuries during the applicable assessment period. The MDS did not capture the Stage 3 pressure injury of the coccyx documented in the clinical record on May 12, 2026.

During an interview on August 6, 2026, at 9:30 A.M., the Nursing Home Administrator (NHA) and Director of Nursing (DON) confirmed that Resident 2's MDS was not coded accurately and did not capture the presence of the Stage 3 pressure injury.

A review of the clinical record revealed Resident 9 was admitted to the facility on February 28, 2023, with diagnoses that included traumatic brain injury (damage to the brain caused by an external force to the head).

A review of a physician's order dated September 23, 2025, directed that Resident 9 remain NPO (nothing by mouth), meaning the resident was not to receive food, fluids, or medications by mouth.

A review of the clinical record revealed Resident 9 received nutrition and medications through a gastrostomy tube (G-tube, a tube inserted directly into the stomach to provide nutrition and medications).

A physician's order dated April 17, 2026, directed staff to administer 1.2 liters of Jevity 1.5 (a liquid nutritional formula) through the feeding tube at a continuous rate of 65 milliliters (mL) per hour by pump until the prescribed amount was delivered.

A review of Resident 9's quarterly Minimum Data Set (MDS), with an Assessment Reference Date of May 18, 2026, revealed Section GG, Functional Abilities and Goals, item GG0130A, Eating, was coded "01," Dependent, indicating the helper completed all of the effort for the activity.

According to the RAI Manual, item GG0130A, Eating, addresses the resident's ability to use suitable utensils to bring food and/or liquid to the mouth and swallow food and/or liquid once the meal is placed before the resident. The RAI Manual directs staff to use Code "88," Not Attempted Due to Medical Condition or Safety Concerns, when the resident does not perform the activity because of a medical condition or safety concern.

The clinical record documented that Resident 9 was NPO and received nutrition through a G-tube. Therefore, the MDS coding of "01," Dependent, for item GG0130A did not accurately reflect the resident's functional status related to eating.

During an interview on August 6, 2026, at 9:30 A.M., the Nursing Home Administrator and Director of Nursing confirmed that Resident 9's MDS was not coded accurately and did not accurately reflect the resident's functional status related to eating.

28 Pa Code 211.10 (c)(d) Resident care policies.

28 Pa. Code 211.12 (c)(d)(1)(3)(5) Nursing services.


 Plan of Correction - To be completed: 09/21/2026


1. Corrective Action for Residents 2 and 9
Resident 2's MDS could not be corrected as a nursing late entry for the Stage 3 pressure injury was submitted after the ARD.
Resident 9's MDS was corrected as appropriate to accurately reflect the resident's NPO status and functional ability related to eating.
2. Identification of Other Residents
The MDS Coordinator will audit current MDS assessments for residents with pressure injuries and residents who are NPO or receive tube feeding to verify accurate coding. Identified errors will be corrected as appropriate.
3. Systemic Changes
RNAC and licensed nurses involved in the assessment process will be re-educated on MDS accuracy, review of the clinical record, coordination with direct-care staff and other disciplines, and applicable RAI Manual coding requirements. Education will specifically address Section M skin conditions and Section GG eating coding.
4. Monitoring
The MDS Coordinator/designee will audit 2 MDS assessments weekly for 4 weeks, then monthly for 2 months for accuracy and consistency with the clinical record. Identified errors will be corrected promptly, with additional education provided as indicated. Audit results will be reviewed through the facility's QAPI process.
5. Compliance
The DON/designee is responsible for implementation and ongoing compliance.

483.21(b)(1)(3) REQUIREMENT Develop/Implement Comprehensive Care Plan:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.21(b) Comprehensive Care Plans
§483.21(b)(1) The facility must develop and implement a comprehensive person-centered care plan for each resident, consistent with the resident rights set forth at §483.10(c)(2) and §483.10(c)(3), that includes measurable objectives and timeframes to meet a resident's medical, nursing, and mental and psychosocial needs that are identified in the comprehensive assessment. The comprehensive care plan must describe the following -
(i) The services that are to be furnished to attain or maintain the resident's highest practicable physical, mental, and psychosocial well-being as required under §483.24, §483.25 or §483.40; and
(ii) Any services that would otherwise be required under §483.24, §483.25 or §483.40 but are not provided due to the resident's exercise of rights under §483.10, including the right to refuse treatment under §483.10(c)(6).
(iii) Any specialized services or specialized rehabilitative services the nursing facility will provide as a result of PASARR recommendations. If a facility disagrees with the findings of the PASARR, it must indicate its rationale in the resident's medical record.
(iv)In consultation with the resident and the resident's representative(s)-
(A) The resident's goals for admission and desired outcomes.
(B) The resident's preference and potential for future discharge. Facilities must document whether the resident's desire to return to the community was assessed and any referrals to local contact agencies and/or other appropriate entities, for this purpose.
(C) Discharge plans in the comprehensive care plan, as appropriate, in accordance with the requirements set forth in paragraph (c) of this section.
§483.21(b)(3) The services provided or arranged by the facility, as outlined by the comprehensive care plan, must-
(iii) Be culturally-competent and trauma-informed.
Observations:

Based on review of facility policy, clinical record review, resident observation, and staff interview, it was determined that the facility failed to implement a comprehensive person-centered care plan intervention intended to promote resident safety by failing to ensure an electronic wandering safety device was in place for one of 12 residents reviewed (Resident 9).

Findings include:

A review of the facility policy titled "Care Plan Process," last reviewed July 1, 2026, indicated the facility will promote coordinated interdisciplinary care through an individualized plan of care based on assessment, planning, treatment, services, and interventions. The policy indicated care will be complete, current, realistic, time-specific, and appropriate to each resident's individual needs.

Clinical record review revealed Resident 9 was admitted to the facility on February 28, 2023, with diagnoses that included traumatic brain injury (damage to the brain caused by a sudden blow, jolt, or other injury to the head).

Review of Resident 9's comprehensive care plan revealed a care plan initiated October 3, 2024, and most recently revised November 18, 2025, identifying Resident 9 as being at risk for wandering. The care plan established a goal for Resident 9 to remain safe and not leave the facility unattended.

The care plan included an intervention, initiated October 3, 2024, and most recently revised February 4, 2025, directing staff to maintain a Wander Guard attached to Resident 9's chair.
A Wander Guard is an electronic safety device used to alert staff when a resident who is at risk for wandering approaches a monitored area or exit.

Observation on August 4, 2026, at 11:28 A.M. revealed Resident 9 seated in the resident's Broda chair (specialized supportive positioning and mobility chair) in a community room in the presence of two activity staff members. The Wander Guard identified in Resident 9's comprehensive care plan was not attached to the Broda chair. The two activity staff members checked Resident 9, including the resident's ankles, and were unable to locate the Wander Guard on the resident or the chair.

During an interview on August 5, 2026, at 11:30 P.M., the Nursing Home Administrator (NHA) and Director of Nursing (DON) confirmed that Resident 9's comprehensive care plan directed staff to maintain a Wander Guard attached to the resident's chair and confirmed that the care-planned safety intervention was not implemented as directed.


28 Pa Code 211.10 (c)(d) Resident care policies.

28 Pa. Code 211.12 (c)(d)(1)(3)(5) Nursing services.


 Plan of Correction - To be completed: 09/21/2026

1. Corrective Action for Resident 9
Resident 9's elopement risk and current safety needs will be reassessed by safety/investigation coordinator. The care plan was updated as appropriate.
2. Identification of Other Residents
The Safety/Investigation Coordinator will identify residents with wandering/elopement safety interventions and audit their care plans to verify that ordered or care-planned electronic wandering devices are in place and functioning. Identified concerns will be corrected immediately.
3. Systemic Changes
Licensed nurses, CNAs, activity staff, and other appropriate direct-care staff will be re-educated on implementing resident-specific care plan interventions, including wandering/elopement precautions. Staff will be instructed to verify required safety devices are present and functioning and to immediately report missing or malfunctioning devices to the nurse.
4. Monitoring
The safety/investigation coordinator/designee will audit residents with wandering/elopement interventions 5 times weekly for 4 weeks, then weekly for 8 weeks to verify care-planned safety interventions are implemented. Identified concerns will be corrected immediately, with staff re-education as indicated. Results will be reviewed through the facility's QAPI process.

483.45(a)(b)(1)-(3) REQUIREMENT Pharmacy Srvcs/Procedures/Pharmacist/Records:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.45 Pharmacy Services
The facility must provide routine and emergency drugs and biologicals to its residents, or obtain them under an agreement described in §483.70(f). The facility may permit unlicensed personnel to administer drugs if State law permits, but only under the general supervision of a licensed nurse.

§483.45(a) Procedures. A facility must provide pharmaceutical services (including procedures that assure the accurate acquiring, receiving, dispensing, and administering of all drugs and biologicals) to meet the needs of each resident.

§483.45(b) Service Consultation. The facility must employ or obtain the services of a licensed pharmacist who-

§483.45(b)(1) Provides consultation on all aspects of the provision of pharmacy services in the facility.

§483.45(b)(2) Establishes a system of records of receipt and disposition of all controlled drugs in sufficient detail to enable an accurate reconciliation; and

§483.45(b)(3) Determines that drug records are in order and that an account of all controlled drugs is maintained and periodically reconciled.
Observations:

Based on clinical record review, review of facility policy, and staff interview, it was determined that the facility failed to implement procedures to maintain complete and accurate records of the receipt, administration, and disposition of controlled medications to permit accurate reconciliation for two of 12 residents reviewed for medication administration (Residents 11 and 35).

Findings include:

A review of the facility policy titled "Controlled Substances," last reviewed July 1, 2026, revealed that the facility will comply with applicable laws, regulations, and other requirements related to the handling, storage, disposal, and documentation of controlled medications. The policy indicated that the nurse administering a controlled medication is responsible for documenting the name of the resident receiving the medication; the name, strength, and dose of the medication; the time and method of administration; the quantity of medication remaining; and the signature of the nurse administering the medication.

A clinical record review revealed that Resident 11 was admitted to the facility on February 12, 2026, with diagnoses that included diabetes mellitus (a condition in which blood sugar levels remain too high) and a pressure ulcer of the sacral region (an area of damaged skin and underlying tissue caused by prolonged pressure over the sacrum, the bone at the base of the spine).

A review of Resident 11's physician orders revealed an order, initiated March 31, 2026, for hydrocodone-acetaminophen 5 milligrams/325 milligrams, one tablet by mouth every 12 hours as needed for breakthrough pain rated 7 through 10 on a pain scale (a tool used to rate pain intensity, typically from 0, meaning no pain to 10, meaning the worst pain possible). Hydrocodone-acetaminophen is a combination opioid pain medication containing hydrocodone and acetaminophen. Hydrocodone-containing combination products are Schedule II controlled substances, medications with accepted medical uses that have a high potential for misuse and dependence.

Review of facility records revealed that the facility used a Controlled Drug Receipt/Record/Disposition Form to account for the receipt, use, remaining quantity, and disposition of controlled medications.

The facility also used a Medication Administration Record (MAR), the clinical record used to document medications administered to a resident, including the medication, date and time of administration, and the staff member who administered the medication.

Comparison of Resident 11's Controlled Drug Receipt/Record/Disposition Form with the MAR from April 3 through August 4, 2026, identified seven instances in which the controlled-drug record documented that a hydrocodone-acetaminophen tablet was removed from the available supply; however, the MAR contained no corresponding documentation that the medication was administered:

April 12, 2026, at 4:45 PM
April 25, 2026, at 3:35 PM
June 20, 2026, at 3:45 PM
June 27, 2026, at 6:45 PM
July 23, 2026, at 3:30 PM
July 30, 2026, at 3:40 PM
August 2, 2026, at 5:30 AM

Comparison of Resident 11's Controlled Drug Receipt/Record/Disposition Form with the MAR from April through August 2026 identified three instances in which the MAR documented that hydrocodone-acetaminophen was administered; however, the Controlled Drug Receipt/Record/Disposition Form contained no corresponding documentation that the medication was removed from the controlled-drug inventory:

April 25, 2026, at 8:36 PM
June 23, 2026, at 4:40 PM
July 23, 2026, at 8:31 PM

Therefore, the facility's two records used to account for the administration and disposition of Resident 11's Schedule II controlled medication could not be reconciled.

A review of Resident 35's physician orders revealed an order, initiated May 8, 2025, for Xanax 0.25 milligram, one tablet by mouth three times daily for anxiety. Xanax, the brand name for alprazolam, is a benzodiazepine medication used to treat anxiety and is classified as a Schedule IV (lower potential for abuse) controlled substance.

Comparison of Resident 35's Controlled Drug Receipt/Record/Disposition Form with the MAR from June 1 through August 5, 2026, identified eight instances in which the controlled-drug record documented that a Xanax 0.25 milligram tablet was removed from the available supply; however, the MAR contained no corresponding documentation that the medication was administered:

June 4, 2026, at 2:00 PM
June 18, 2026, at 9:00 PM
June 19, 2026, at 9:00 PM
June 21, 2026, at 9:00 PM
June 28, 2026, at 9:00 PM
July 23, 2026, at 9:00 PM
July 25, 2026, at 9:00 PM
July 30, 2026, at 9:00 PM

The facility's records did not provide a complete and accurate account of the administration and disposition of Resident 35's controlled medication and could not be accurately reconciled.

During an interview on August 6, 2026, at 9:05 AM, the Director of Nursing (DON), reviewed the discrepancies identified between the Controlled Drug Receipt/Record/Disposition Forms and the Medication Administration Records for Residents 11 and 35.

The facility failed to maintain controlled-medication records in sufficient detail to provide an accurate accounting and reconciliation of hydrocodone-acetaminophen for Resident 11 and Xanax for Resident 35.


28 Pa Code 211.5(f)(xi) Medical records

28 Pa Code 211.9(a)(1)(k) Pharmacy services.

28 Pa Code 211.12 (d)(1)(3)(5) Nursing services.

28 Pa Code 211.10 Resident care policies.


 Plan of Correction - To be completed: 09/21/2026

1. Corrective Action for Residents 11 and 35
The DON/designee will review and reconcile the controlled-medication records and MARs for Residents 11 and 35. Identified discrepancies will be investigated and corrected when appropriate.
2. Identification of Other Residents
The DON/designee will audit residents currently receiving controlled medications to compare controlled-drug records with the MAR and verify accurate administration. Any discrepancies will be immediately investigated and addressed.
3. Systemic Changes
Licensed nurses who administer controlled medications will be re-educated on the facility's controlled-substance policy and requirements for accurate, timely documentation. Education will include documenting controlled medications on both the MAR and controlled-drug record as applicable and immediately reporting any discrepancies.
4. Monitoring
The DON/designee will audit 4 controlled-medication records weekly for 4 weeks, then weekly for 8 weeks to verify reconciliation with the MAR and controlled-drug inventory. Discrepancies will be investigated immediately, and additional staff education or corrective action will be completed as indicated. Results will be reviewed through the facility's QAPI process.


Back to County Map


  
Home : Press Releases : Administration
Health Planning and Assessment : Office of the Secretary
Health Promotion and Disease Prevention : Quality Assurance



Copyright © 2001 Commonwealth of Pennsylvania. All Rights Reserved.
Commonwealth of PA Privacy Statement

Visit the PA Power Port